Protein engineering to target complement evasion in cancer

Area of Science:

• Immunology
• Oncology
• Protein Engineering

Background:

• The complement system enhances immune responses via plasma factors, aiding in pathogen and tumor cell elimination.
• Tumor cells employ complement inhibitory factors to evade immune detection and destruction, particularly as cancers progress.
• The membrane attack complex (MAC) is a key effector of complement-mediated cell lysis.

Purpose of the Study:

• To review the role of the classic complement pathway and inhibitory factors in cancer immune evasion.
• To explore protein engineering strategies for enhancing complement fixation or reversing complement resistance in oncology.
• To discuss therapeutic approaches involving engineered antibodies and complement inhibitors.

Main Methods:

• Review of literature on complement system function in cancer.
• Analysis of tumor cell complement evasion mechanisms.
• Examination of protein engineering techniques applied to complement therapeutics.

Main Results:

• Tumor cells significantly up-regulate complement inhibitory factors to escape immune surveillance.
• Current protein engineering efforts focus on enhancing antibody-mediated complement fixation.
• Strategies include neutralizing inhibitory proteins and developing targeted complement inhibitors.

Conclusions:

• Overcoming complement-mediated immune evasion is crucial for effective cancer therapy.
• Engineered antibodies and targeted complement inhibitors show promise in reversing tumor resistance.
• Protein engineering offers novel therapeutic avenues to improve cancer treatment outcomes by modulating the complement system.